Diagnos Laboratorium Utama Tbk. vs Intikeramik Alamasri Industri Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Intikeramik Alamasri Industri Tbk. trades at Rp20 (market cap 266.12B). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| DGNS | IKAI | |
|---|---|---|
Market Cap | 308B | 266.12B |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Read more on IKAI →